KIM CHRISTOPHER (Chairman and CMO) purchased 27.50K shares of APIMEDS PHARMACEUTICALS US, INC. on the open market
Open‑market purchase worth $50.4K. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 5/15/2025ACC: 0001474506-25-000096
DirectorOfficer· Chairman and CMO
Since Mar 2025
+27.50K
Net shares
Net buyer
$50.4K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
27.50K acquired
Non-Derivative Transactions2
Common Stock, par value $0.01 per share
Direct
Shares
+19.77K
Price / share
$1.82
Trade value
$35.98K
% of position
New position
5/13/2025
0.00→19.77K
Common Stock, par value $0.01 per share
Direct
Shares
+7.73K
Price / share
$1.86
Trade value
$14.38K
% of position
39.1%
5/14/2025
19.77K→27.50K
Total
Net shares
+27.50K
Net value
$50.36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.01 per share Direct | 5/13/2025 | P · Purchase | +19.77K | $1.82 | $35.98K | New position | 0.00 | 19.77K |
| Common Stock, par value $0.01 per share Direct | 5/14/2025 | P · Purchase | +7.73K | $1.86 | $14.38K | 39.1% | 19.77K | 27.50K |
| Total | +27.50K | $50.36K | ||||||
Derivative Transactions0
No derivative transactions reported